EMTRIVA Trademark

Trademark Overview

On Friday, April 18, 2003, a trademark application was filed for EMTRIVA with the United States Patent and Trademark Office. The USPTO has given the EMTRIVA trademark a serial number of 78239710. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, May 7, 2024. This trademark is owned by Gilead Sciences, Inc.. The EMTRIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious conditions
emtriva

General Information

Serial Number78239710
Word MarkEMTRIVA
Filing DateFriday, April 18, 2003
Status800 - REGISTERED AND RENEWED
Status DateTuesday, May 7, 2024
Registration Number2852092
Registration DateTuesday, June 8, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 2, 2003

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of infectious conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 4, 2003
Primary Code005
First Use Anywhere DateMonday, July 7, 2003
First Use In Commerce DateMonday, July 7, 2003

Trademark Owner History

Party NameGilead Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Tuesday, September 23, 2003EXAMINERS AMENDMENT E-MAILED
Monday, September 29, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 23, 2003ASSIGNED TO EXAMINER
Friday, June 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 12, 2003NOTICE OF PUBLICATION
Tuesday, December 2, 2003PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 4, 2004PAPER RECEIVED
Thursday, March 4, 2004USE AMENDMENT FILED
Tuesday, March 16, 2004STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 24, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 8, 2004REGISTERED-PRINCIPAL REGISTER
Friday, June 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 20, 2009TEAS SECTION 8 & 15 RECEIVED
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 25, 2009ASSIGNED TO PARALEGAL
Saturday, August 29, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 19, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 19, 2013TEAS SECTION 8 & 9 RECEIVED
Thursday, June 20, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, June 20, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, June 20, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 18, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, May 7, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 7, 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, May 7, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, May 7, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, June 8, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

emtriva conditions infectious treatment preparations pharmaceutical